Belmac
This article was originally published in The Tan Sheet
Executive Summary
Appoints former SmithKline Beecham exec Donald Boultbee president and CEO. At SmithKline, Boultbee served as area VP for Latin America and certain Middle East and Far East markets. He most recently served as a "strategic planning consultant with major pharmaceutical companies and biotech firms, and as director of Euromedia," Belmac said. Boultbee replaces Michael Harshbarger, who recently left the Tampa-based firm ("The Tan Sheet" July 26, In Brief).
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning